Pfizer Inc (PFE)
26.36
+0.59
(+2.29%)
USD |
NYSE |
Dec 20, 16:00
26.36
0.00 (0.00%)
After-Hours: 20:00
Pfizer Cash from Investing (Quarterly): -2.057B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -210.00M |
| Gilead Sciences Inc | -710.00M |
| Johnson & Johnson | -3.128B |
| Eli Lilly and Co | -4.005B |
| Moderna Inc | 721.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 6.714B |
| Cash from Financing (Quarterly) | -4.636B |
| Free Cash Flow | 8.227B |
| Free Cash Flow Per Share (Quarterly) | 1.063 |
| Free Cash Flow to Equity (Quarterly) | 8.123B |
| Free Cash Flow to Firm (Quarterly) | 6.697B |
| Free Cash Flow Yield | 5.49% |